Exchange: NYSEMkt·Updated 09:50 AM EDT
CANF logo

CANF Can-Fite BioPharma Ltd.

$2.15
$0.01
(0.46%)
Today
Mkt Cap$6.55M
Vol7,261.00

About CANF

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
48

Neutral Sentiment

How do you feel about CANF?

Advertisement|Remove ads.